http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3035567-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 |
filingDate | 1980-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac6e41a7161abd305cd32543f695a7cf |
publicationDate | 1982-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | DE-3035567-A1 |
titleOfInvention | AGENT AGAINST THEILERIOSEN, NEW CHINAZOLINON SALTS AND THEIR USE |
abstract | New agents against theileriasis contain a 3-(3-(2-piperidinyl)- acetonyl) -4(3H)-quinazolinone deriv. (I) in admixture with a pharmaceutically usual carrier and/or constituent. In (I), R1 and R2 are halogen, CF3, 1-4C alkoxy or CH3; Y is O, S or NOH; R is OH or 1-4C acyloxy; and X is the anion of lactic acid, acetic acid or aceturic acid. Specific (I) rac-trans-7-bromo-6-chloro-3 (3-(3-hydroxy-2-piperidyl) acetonyl)-4(3H)-quinazolinone lactate, aceturate and acetate are claimed.The lactates, acetates and aceturates (I) have better solubility than the corresponding hydrochlorides and are suitable for oral admin. in the form of aq.-solns. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108440498-A |
priorityDate | 1979-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.